Safety aspects of delivery and monitoring of nitric oxide during mechanical ventilation

Acta Anaesthesiologica Scandinavica

Volumn 40, Issue 3, 1996, Pages 302-310

  Nathorst Westfelt, U ^a   Lundin, S ^a   Stenqvist, O ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Inhalation; Nitric oxide; Nitrogen dioxide mechanical ventilation

Indexed keywords

NITRIC OXIDE; NITROGEN DIOXIDE;

ARTICLE; ARTIFICIAL VENTILATION; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG SAFETY; PATIENT MONITORING; PRIORITY JOURNAL;

EID: 0029918988     PISSN: 00015172     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-6576.1996.tb04437.x     Document Type: Article

References (28)

1. Stenqvist O, Kjelltoft B. Lundin S. Evaluation of a new system for ventilatory administration of nitric oxide. Acta Anaesthesiol Scand 1993: 37: 687-691.
2. Moncada S. Higgs A. The L-Arginine-nitric oxide pathway. N Engl J Med 1993: 329: 2002-2012.
3. Palmer RMJ, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987: 524-526.
4. Pepke-Zabka TWH, Dinh-Xuan AT, Stone D, Wallwork J. Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension. Lancet 1991: 338: 1173-1174.
5. Frostell C, Fratacci M-D, Wain J, Jones R, Zapol WM. Inhaled nitric oxide a selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction. Circulation 1991: 83: 2038-2047.
6. Girard C, Lehot J-J, Pannetier J-C, Filley S, Ffrench P, Estanove S. Inhaled nitric oxide after mitral valve replacement in patients with chronic pulmonary artery hypertension. Anesthesiology 1992: 77: 880-883.
7. Rossaint R, Falke K J, Lopez F, Slama K, Pison U, Zapol WM. Inhaled nitric oxide for the adult respiratory distress syndrome. N Engl J Med 1993: 328: 399-405.
8. Puybasset L, Rouby JJ, Mourgeon E, Stewart TE, Cluzel P, Arthaud M, et al. Inhaled nitric oxide in acute respiratory failure: dose response curves. Intensive Care Med 1994: 20: 319-327.
9. Kinsella J, Neish S, Shaffer E, Abman S. Low-dose inhalational nitric oxide in persistant pulmonary hypertension of the newborn. Lancet 1992: 340: 819-820
10. Roberts Jr. JD, Lang P, Bigatello LM, Vlahakes GJ, Zapol WM. Inhaled nitric oxide in congenital heart disease. Circulation 1992: 87: 447-453.
11. Wessel DL, Adatia I, Thompson JE, Hickey PR. Delivery and monitoring of inhaled nitric oxide in patients with pulmonary hypertension. Crit Care Med 1994: 22: 930-938.
12. Rabson SR, Quilliam JH, Goldblatt E. The elimination of nitrous fumes from blasting gases. J S Afr Inst Min Metall 1960: 61: 152-182.
13. England C, Corcoran W. Kinetics and mechanisms of the gasphase reaction of water wapor and nitrogen dioxide. Ind Eng Chem Fundam 1974: 13: 373-384.
14. Clutton-Brock J. Two cases of poisoning by contamination of nitrous oxides of nitrogen during anaesthesia. Br J Anaesth 1967: 39: 388-392.
15. Ignarro L, Buga GM, Wood KS, Byrns RE, Chaduri G. Endothelium derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci USA 1987: 84: 9265-9269.
16. Centers for disease control: Recommendations for occupational safety and health standard. Morbidity and Mortality Weekly Report (MMWR) 1988: 37: NoS-7-(21).
17. 2 as markers of altered surfactant metabolism. Lung 1994: 172: 61-72.
18. Jörres R, Nowak D, Grimminger F, Seeger W, Oldigs M. Magnussen H. The effect of 1 ppm nitrogen dioxide on bronchoalveolar lavage cells and inflammatory mediators in normal and asthmatic subjects. Eur Respir J 1995: 8: 416-424.
19. Ben-Jebria A, Marthan R. Effect of in vitro nitrogen dioxide exposure on human bronchial smooth muscle response. Am Rev Respir Dis 1992: 146: 378-382.
20. Gaston B, Drazen J, Localzo J, Stamler J. The biology of nitrogen oxides in the airways. Am J Respir Crit Care Mcd 1994: 2: 538-551.
21. Foubert L, Fleming B, Latimer R, Jonas M, Oduro A. Safety guidelines for use of nitric oxide. Lancet 1992: 339: 1615-1616.
22. 2 at EMEP stations. Proc. EMEP workshop on Measurements of Nitrogen-Containing Compounds, Les Diablerets, Switzerland, 1992.
23. Miller CC. Chemilumenescence analysis and nitrogen dioxide measurement. Lancet 1994: 343: 300-301.
24. Etches PC, Harris MI, McKinley R, Finer NN. Clinical monitoring of inhaled nitric oxide: Comparison of chemiluminescent and electrochemical sensors. Biomed Instruinen & Technol 1995: 29: 134-140.
25. Ishibe Y, Sato T, Hayashi T, Kaot N. Effective absorbtion of nitrogen dioxide with soda lime. Br J Anaesth 1995: 74: 107.
26. Pickett JA, Mahmood N, Latimer RD, Powroznyk A, Ghosh S. Answer to Ishibe et al. Br J Anaesth 1995: 74: 107-108.
27. Pickett JA, Moors AH, Latimer RD, Mahmood N, Ghosh S. The role of soda lime during the administration of inhaled nitric oxide. Br J Anaesth 1994: 72: 683-685.
28. Moors AH, Pickett JA, et al. Nitric oxide administration. Anaesth Intensive Care 1994: 22: 310-312.